Skip to content

LNTH · NASDAQ

Lantheus Holdings (LNTH) Stock Price & Fundamentals

$772.43+0.27%+$2.06End-of-day price as of Oct 9, 2026

Lantheus Holdings (LNTH) closed at $772.43 on Oct 9, 2026, up 0.27% from the previous close of $770.37.

Share price, past year

1Y −2.54%

52-week range $742.88 – $922.54. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$772.43
Sep 30, 2026$783.34
Aug 31, 2026$761.95
Jul 31, 2026$793.83
Jun 30, 2026$794.82
May 29, 2026$866.51
Apr 30, 2026$892.21
Mar 31, 2026$856.78
Feb 27, 2026$835.09
Jan 30, 2026$834.37
Dec 31, 2025$831.69
Nov 28, 2025$821.74
Oct 31, 2025$772.31

Key statistics

Market cap
$50.41B
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
$1.56B
Net income (TTM)
$275.31M
Shares outstanding
65.3M
Dividend yield
—
52-week range
$742.88 – $922.54

Lantheus Holdings's market cap is $50.41B, based on a share price of $772.43 and 65.3M shares outstanding as of Jun 30, 2026.

Financials

Lantheus Holdings reported revenue of $1.54B for fiscal 2025, up 0.50% from fiscal 2024.

Lantheus Holdings earned net income of $233.56M in fiscal 2025, a net margin of 15.2%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Lantheus Holdings annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$1.54B+0.5%$233.56M15.2%$3.41—
FY2024ended Dec 31, 2024$1.53B+18.3%$312.44M20.4%$4.36—
FY2023ended Dec 31, 2023$1.30B+38.7%$326.66M25.2%$4.65—
FY2022ended Dec 31, 2022$935.06M+119.9%$28.07M3.0%$0.40—
FY2021ended Dec 31, 2021$425.21M+25.3%−$71.28M−16.8%−$1.06—
FY2020ended Dec 31, 2020$339.41M−2.3%−$13.47M−4.0%−$0.25—
FY2019ended Dec 31, 2019$347.34M+1.2%$31.67M9.1%$0.79—
FY2018ended Dec 31, 2018$343.37M+3.6%$40.52M11.8%$1.03—
FY2017ended Dec 31, 2017$331.38M+9.8%$123.39M37.2%$3.17—
FY2016ended Dec 31, 2016$301.85M———$0.82—
Lantheus Holdings quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$388.18M$75.03M$1.11
Q1 FY2026ended Mar 31, 2026$377.33M$118.42M$1.80
Q4 FY2025ended Dec 31, 2025$406.79M$54.09M—
Q3 FY2025ended Sep 30, 2025$384.01M$27.77M$0.41
Q2 FY2025ended Jun 30, 2025$378.05M$78.76M$1.12
Q1 FY2025ended Mar 31, 2025$372.76M$72.95M$1.02
Q4 FY2024ended Dec 31, 2024$391.11M−$11.79M—
Q3 FY2024ended Sep 30, 2024$378.73M$131.09M$1.79

Company profile

Name
Lantheus Holdings, Inc.
Ticker
LNTH
Exchange
NASDAQ
Industry (SEC SIC)
In Vitro & In Vivo Diagnostic Substances
Headquarters
201 Burlington Road, South Building, Bedford, MA 01730
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001521036

Recent SEC filings

Frequently asked questions

What is Lantheus Holdings's stock price?

Lantheus Holdings (LNTH) closed at $772.43 on Oct 9, 2026, up 0.27% from the previous close of $770.37.

What is Lantheus Holdings's market cap?

Lantheus Holdings's market cap is $50.41B, based on a share price of $772.43 and 65.3M shares outstanding as of Jun 30, 2026.

How much revenue does Lantheus Holdings make?

Lantheus Holdings reported revenue of $1.54B for fiscal 2025, up 0.50% from fiscal 2024.

Does Lantheus Holdings pay a dividend?

Lantheus Holdings's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Lantheus Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures